Search
Mucopolysaccharidosis VII. Sly Syndrome
smpdb.ca/view/SMP0000556DiseaseMucopolysaccharidosis type VII (MPS VII), also called Sly syndrome, is a rare inborn error of metabolism (IEM) and autosomal recessive disorder caused by mutations in the GUSB gene. … It is estimated that MPS VII affects 1 in 250,000 individuals.
Drugs: Pyridoxal phosphate · NADH · ATP · Calcium · Magnesium cation · Uridine diphosphate glucose +4 moreMucopolysaccharidosis VII. Sly Syndrome
smpdb.ca/view/SMP0125762DiseaseIt is estimated that MPS VII affects 1 in 250,000 individuals. … Mucopolysaccharidosis type VII (MPS VII), also called Sly syndrome, is a rare inborn error of metabolism (IEM) and autosomal recessive disorder caused by mutations in the GUSB gene.
Drugs: Pyridoxal phosphate · NADH · ATP · Calcium · Magnesium cation · Uridine diphosphate glucose +4 moreGlycogenosis, Type VII. Tarui Disease
smpdb.ca/view/SMP0000531DiseaseGlycogen storage disease, Type VII, also called GSD VII and Tarui Disease, is an inborn error of metabolism (IEM) and metabolic disorder caused by a defective 6-phosphofructokinase. 6-phosphofructokinase … Currently, the major treatment for Glycogen storage disease, Type VII is associated with diet management.
Drugs: Pyruvic acid · NADH · ATP · Potassium cation · Magnesium cation · 2-phospho-D-glyceric acid +3 moreGlycogenosis, Type VII. Tarui Disease
smpdb.ca/view/SMP0125707DiseaseGlycogen storage disease, Type VII, also called GSD VII and Tarui Disease, is an inborn error of metabolism (IEM) and metabolic disorder caused by a defective 6-phosphofructokinase. 6-phosphofructokinase … Currently, the major treatment for Glycogen storage disease, Type VII is associated with diet management.
Drugs: Pyruvic acid · NADH · ATP · Potassium cation · Magnesium cation · 2-phospho-D-glyceric acid +3 moreCoagulation Factor VII Human Action Pathway
smpdb.ca/view/SMP0126839Drug actionIt is broken down via catabolism in the body. … Coagulation factor VII human is a coagulation factor also known as Balfaxar, Beriplex, Kcentra and Octaplex to treat hemophilia and Glanzmann's thrombasthenia.
Glycogenosis, Type VI. Hers Disease
smpdb.ca/view/SMP0125761DiseaseGlycogen storage disease type VI has been reported in approximately 11 people at least. … Glycogen storage disease type VI, also called GSDVI or Hers disease, is a rare inborn error of metabolism (IEM) and autosomal recessive disorder caused by a defective liver glycogen phosphorylase.
Drugs: Pyridoxal phosphate · NADH · ATP · Calcium · Magnesium cation · Uridine diphosphate glucose +4 moreGlycogenosis, Type VI. Hers Disease
smpdb.ca/view/SMP0000555DiseaseGlycogen storage disease type VI has been reported in approximately 11 people at least. … Glycogen storage disease type VI, also called GSDVI or Hers disease, is a rare inborn error of metabolism (IEM) and autosomal recessive disorder caused by a defective liver glycogen phosphorylase.
Drugs: Pyridoxal phosphate · NADH · ATP · Calcium · Magnesium cation · Uridine diphosphate glucose +4 more